Patient Case Study: Respiratory Distress Management.<\/p>\n
Respiratory distress is a critical condition requiring immediate medical attention. This paper presents a fictional case study of a patient admitted to the hospital on September 5th for respiratory distress. The focus is on the patient’s medication administration record (MAR), clinical assessments, and management strategies. The aim is to provide a comprehensive overview of the therapeutic interventions and nursing considerations involved in treating respiratory distress.<\/p>\n
Medication Administration Record (MAR)
\nMedication 1: Albuterol (Proventil)
\nClass: Bronchodilator (Therapeutic), Beta-2 Agonist (Pharmacologic)
\nIndications: Used to relieve bronchospasm in conditions such as asthma and COPD.
\nDose\/Route\/Frequency: 2.5 mg via nebulizer every 4-6 hours as needed.
\nContraindications: Hypersensitivity to albuterol.
\nNursing Considerations: Monitor respiratory status and lung sounds before and after administration. Assess for paradoxical bronchospasm. Educate the patient on proper inhalation technique.
\nSide Effects: Tremors, nervousness, tachycardia.
\nPatient Teaching: Instruct on the importance of adhering to prescribed doses and recognizing signs of worsening symptoms.
\nMedication 2: Prednisone
\nClass: Corticosteroid (Therapeutic), Glucocorticoid (Pharmacologic)
\nIndications: Reduces inflammation in respiratory conditions.
\nDose\/Route\/Frequency: 40 mg orally once daily.
\nContraindications: Systemic fungal infections, hypersensitivity.
\nNursing Considerations: Monitor blood glucose levels, especially in diabetic patients. Assess for signs of infection. Taper dose gradually to avoid adrenal insufficiency.
\nSide Effects: Hyperglycemia, increased risk of infection, mood changes.
\nPatient Teaching: Advise on potential side effects and the importance of not abruptly discontinuing the medication.
\nMedication 3: Furosemide (Lasix)
\nClass: Diuretic (Therapeutic), Loop Diuretic (Pharmacologic)
\nIndications: Manages fluid overload in heart failure or pulmonary edema.
\nDose\/Route\/Frequency: 40 mg IV once daily.
\nContraindications: Anuria, hypersensitivity to sulfonamides.
\nNursing Considerations: Monitor electrolytes, particularly potassium. Assess fluid status and daily weights. Watch for signs of dehydration.
\nSide Effects: Hypokalemia, dehydration, hypotension.
\nPatient Teaching: Encourage potassium-rich foods and report any signs of electrolyte imbalance.
\nMedication 4: Ceftriaxone (Rocephin)
\nClass: Antibiotic (Therapeutic), Cephalosporin (Pharmacologic)
\nIndications: Treats bacterial infections potentially causing respiratory distress.
\nDose\/Route\/Frequency: 1 g IV every 24 hours.
\nContraindications: Hypersensitivity to cephalosporins.
\nNursing Considerations: Monitor for signs of allergic reaction. Assess renal function. Ensure culture and sensitivity tests are performed.
\nSide Effects: Diarrhea, rash, elevated liver enzymes.
\nPatient Teaching: Complete the full course of antibiotics even if symptoms improve.
\nMedication 5: Enoxaparin (Lovenox)
\nClass: Anticoagulant (Therapeutic), Low Molecular Weight Heparin (Pharmacologic)
\nIndications: Prevents thromboembolic events in immobilized patients.
\nDose\/Route\/Frequency: 40 mg subcutaneously once daily.
\nContraindications: Active bleeding, heparin-induced thrombocytopenia.
\nNursing Considerations: Monitor for signs of bleeding. Check platelet counts regularly. Educate on proper injection technique.
\nSide Effects: Bleeding, anemia, thrombocytopenia.
\nPatient Teaching: Report any unusual bleeding or bruising.
\nClinical Assessment and Management
\nPatient Information
\nRoom: 101
\nPatient\/Age\/Sex: John Doe, 65, Male
\nAttending & Consults: Dr. Smith, Pulmonology
\nAllergies: Penicillin
\nAdmit Date: September 5th
\nIsolation & Organism: None
\nCode Status: Full Code
\nPrimary Diagnoses
\nAcute respiratory distress syndrome (ARDS)
\nChronic obstructive pulmonary disease (COPD)
\nChief Complaint and History of Present Illness
\nThe patient presented with severe shortness of breath, wheezing, and cyanosis. Symptoms began acutely two days prior to admission, with a history of COPD exacerbations.<\/p>\n
Past Medical and Surgical History
\nMedical: COPD, hypertension, type 2 diabetes.
\nSurgical: Appendectomy at age 30.
\nNeurological and Psychological Assessment
\nGCS: 15
\nPrimary Language: English
\nMood\/Behavior: Anxious but cooperative.
\nLaboratory and Diagnostic Data
\nGFR: 60 mL\/min
\nHgbA1C: 7.5%
\nBNP: 150 pg\/mL
\nABG: pH 7.35, pCO2 50 mmHg, HCO3 28 mEq\/L, pO2 60 mmHg
\nRespiratory Assessment
\nO2 Delivery: 4 LPM via nasal cannula
\nO2 Sat Trends: 88-92%
\nLung Sounds: Bilateral wheezing, diminished bases.
\nPlan of Care
\nPriority Problem #1: Impaired Gas Exchange
\nAssessment Data: Low oxygen saturation, wheezing, cyanosis.
\nS.M.A.R.T. Goal: Improve oxygen saturation to above 92% within 24 hours.
\nInterventions:
\nAssess\/Monitor: Continuous pulse oximetry, ABG analysis every 6 hours.
\nManage: Administer bronchodilators and corticosteroids as prescribed.
\nEducate: Teach breathing exercises and the importance of medication adherence.
\nEvaluation: Goal met if oxygen saturation improves.
\nPriority Problem #2: Risk for Infection
\nAssessment Data: Recent antibiotic initiation, COPD history.
\nS.M.A.R.T. Goal: Prevent infection during hospital stay.
\nInterventions:
\nAssess\/Monitor: Monitor WBC count and temperature daily.
\nManage: Administer antibiotics as prescribed, maintain aseptic technique.
\nEducate: Importance of hand hygiene and completing antibiotics.
\nEvaluation: Goal met if no signs of infection develop.
\nPriority Problem #3: Fluid Volume Overload
\nAssessment Data: Edema, elevated BNP.
\nS.M.A.R.T. Goal: Reduce edema and maintain stable weight.
\nInterventions:
\nAssess\/Monitor: Daily weights, intake and output.
\nManage: Administer diuretics, restrict fluid intake as ordered.
\nEducate: Importance of fluid restriction and monitoring weight.
\nEvaluation: Goal met if edema decreases and weight stabilizes.
\nConclusion
\nEffective management of respiratory distress involves a multidisciplinary approach, focusing on medication administration, continuous monitoring, and patient education. By addressing the primary problems of impaired gas exchange, infection risk, and fluid overload, healthcare providers can improve patient outcomes and enhance quality of care.<\/p>\n
References
\nGlobal Initiative for Chronic Obstructive Lung Disease. (2023). Global strategy for the diagnosis, management, and prevention of COPD. Retrieved from GOLD website
\nNational Heart, Lung, and Blood Institute. (2022). Acute respiratory distress syndrome. Retrieved from NHLBI website
\nAmerican Thoracic Society. (2021). Guidelines for the management of COPD. American Journal of Respiratory and Critical Care Medicine, 203(1), 24-56.
\nMayo Clinic. (2020). Prednisone: Uses, side effects, and precautions. Retrieved from Mayo Clinic website<\/p>\n
=================<\/p>\n
The patient is in the hospital for a respiratory destress he came in September 5th. all the information you need you can come up with. patient is fictional so you can put whatever you like. if it doesn’t apply to the patient you don’t have to fill it in. Include 5 medications in the MAR you only need to put there 5 medication. <\/p>\n
Medication
\n(Generic & Brand Names)\tClass
\n(Therapeutic & Pharmacologic)\tIndications
\n(Why is pt. taking this drug?)\tDose
\nRoute Frequency\tContraindications\tNursing Considerations\tSide Effects\tPt. Teaching<\/p>\n
Medication
\n(Generic & Brand Names)\tClass
\n(Therapeutic & Pharmacologic)\tIndications
\n(Why is pt. taking this drug?)\tDose
\nRoute Frequency\tContraindications\tNursing Considerations\tSide Effects\tPt. Teaching<\/p>\n
Room Patient\/Age\/Sex Attending & consults Allergies Admit date Isolation & organism Code status
\nPrimary diagnoses
\nCC\/HPI
\nPast medical hx
\nPast surgical hx
\nNeuro\/Psych GCS
\nPrimary language Eyes _____
\nLevel of consciousness Verbal _____
\nOrientation & follow commands Motor _____
\nMood\/behavior Total _____
\nPupils
\nMuscle strength: LUE _____ \/ RUE _____ \/ LLE _____ \/ RLE _____
\nLabs BGM frequency _____ \/ 07 _____ 11 _____ 17 _____ 21 _____<\/p>\n
GFR ________ HgbA1C ________
\nTroponin ________ Lactate ________
\nBNP ________ Procal ________
\nCK ________ CRP ________
\nD-dimer ________ ESR ________
\nFibrinogen ________ Amylase ________
\nAmmonia ________ Lipase ________
\nUA _________________________________
\nCultures ___________________________
\n____________________________________
\nCardiac Echo EF _____ %
\nHeart rate trends
\nTele rhythm trends
\nSBP\/MAP trends & goal parameters
\nTemp trends & method\/fevers & Tmax
\nPulses: L rad _____ \/ R rad _____ \/ L ped _____ \/ R ped _____
\nEdema & grading
\n[ ] Pacemaker \/ [ ] AICD
\nRespiratory IS [ ] & trends\/max _____ ml
\nLung sounds & work of breathing\/rhythm
\nO2 delivery _____ @ _____ LPM \/ _____%
\nO2 sat trends
\nSecretion amt & character\/suction method
\nChest tube(s) output & character
\nABG date _____: pH _____ \/ pCO2 _____ \/ HCO3 _____ \/ pO2 _____
\nGI Lt NG \/ Rt NG taped @ _____ cm \/ PEG
\nContinent\/incontinent Suction __________ \/ Output _____ ml
\nLast BM & character Current TF rate @ _____ ml\/hr
\nBowel sounds TF goal rate _____ ml\/hr
\nAbdomen appearance & palpation TF max residual _____ ml
\nDiet\/TF formula
\nRectal tube\/colostomy output & character
\nFluid restriction _____ ml\/day
\nDiagnostics\/Imaging 12-lead ECG
\nXR
\nCT
\nMRI
\nUltrasound
\nEEG
\nGU Foley insert date _____ Indication __________
\nContinent\/incontinent Last bladder scan _____ ml @ _____
\nVoiding method Last I&O cath _____ ml @ _____
\nShift\/hourly urine output
\nUrine character
\nHD sched __________ & last HD amt removed _____ ml
\nSpecialty: Advanced Med\/Surg
\nNeuro\/Psych \u2013 Richmond Agitation-Sedation Scale
\nRASS
\nCardiac \u2013 Hemodynamics
\nPA cath @ _____ cm
\nCI _____ \/ SvO2 _____ \/ CVP _____ \/ PAP _____ \/ SVR _____
\nRespiratory \u2013 Artificial airway & mechanical ventilation
\nETT size _____ taped @ _____ cm @ teeth \/ gum \/ lip
\nTrach brand __________ & size _____
\nVent mode ____________
\nRate _____ VT\/PS _____
\nFiO2 _____% PEEP _____
\nGI \u2013 Enteral tube
\nOG taped @ _____ cm
\nMusculoskeletal\/Safety & Mobility [ ] SCDs [ ] VTE ppx meds
\nPain & scale utilized
\nAssistive devices
\nLevel of assist
\nCalls for assist\/safety concerns
\nRestraint type & location
\nSitter\/tele-sitter
\nRehab consults: [ ] PT [ ] OT [ ] SLP
\nSkin & Drains\/Tubes
\nPressure injuries\/wounds
\nWound tx\/dressings output & character
\nDrains\/tubes output & character
\nWound care consult [ ]
\nOTOs\/PRNs given & time last given To-do\/Follow-up\/Notes
\nIV Lines<\/p>\n
Continuous IV Drips
\nHct
\nHgb
\nWBC Plt
\nNa Cl BUN
\nGlu
\nK CO2(HCO3) Cr
\nBili
\nAST ALT
\nPT
\naPTT
\nINR
\nPhos
\nCa Mag
\nAlk
\nPhos
\nAlb
\nShift Notes Vitals 08\/20 12\/00 16\/04
\n07\/19 08\/20 09\/21 10\/22
\nTemp &
\nsource
\nHR &
\nrhythm
\n11\/23 12\/00 13\/01 14\/02
\nBP & MAP
\nResp
\nrate
\n15\/03 16\/04 17\/05 18\/06
\nSpO2 &
\ndelivery
\nmethod
\nPain &
\npain
\nscale
\nused
\nMedication Administration Record \u2013 provide 5 most critical\/priority medications
\nGeneric & trade name Pharm class Dose Route Freq Indication(s) r\/t patient Common SEs\/ADEs (at least 3) Nursing considerations (at least 3)
\nPlan of Care (Clinical Judgment Plan)
\nPriority problem #1 [hypothesis]:
\nPertinent assessment data [cues]:
\nS.M.A.R.T. goal\/outcome #1 [solution]:
\nInterventions with frequency & rationale [actions]:
\nAssess\/monitor:
\nManage:
\nEducate:
\nEvaluation [evaluate]: Met \/ Not met
\nRecommendations (If goal\/outcome not met):
\nPriority problem #2 [hypothesis]:
\nPertinent assessment data [cues]:
\nS.M.A.R.T. goal\/outcome #2 [solution]:
\nInterventions with frequency & rationale [actions]:
\nAssess\/monitor:
\nManage:
\nEducate:
\nEvaluation [evaluate]: Met \/ Not met
\nRecommendations (If goal\/outcome not met):
\nPriority problem #3 [hypothesis]:
\nPertinent assessment data [cues]:
\nS.M.A.R.T. goal\/outcome #3 [solution]:
\nInterventions with frequency & rationale [actions]:
\nAssess\/monitor:
\nManage:
\nEducate:
\nEvaluation [evaluate]: Met \/ Not met
\nRecommendations (If goal\/outcome not met): \t\t\t\t\t\t\t<\/p>\n","protected":false},"excerpt":{"rendered":"
Patient Case Study: Respiratory Distress Management. Respiratory distress is a critical condition requiring immediate medical attention. This paper presents a fictional case study of a patient admitted to the hospital on September 5th for respiratory distress. The focus is on the patient’s medication administration record (MAR), clinical assessments, and management strategies. The aim is to […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5357,3223,1129,5356],"tags":[5355,5353,5354,5352],"class_list":["post-13233","post","type-post","status-publish","format-standard","hentry","category-help-writing-nursing-case-study-analysis-assignment","category-medical-case-study-answer-sample","category-nursing-case-study-writing-help-examples-how-to-guide","category-patient-case-study-assignment-help","tag-copd-management","tag-medication-administration","tag-patient-care-plan","tag-respiratory-distress"],"_links":{"self":[{"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/posts\/13233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/comments?post=13233"}],"version-history":[{"count":0,"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/posts\/13233\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/media?parent=13233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/categories?post=13233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.colapapers.com\/us\/wp-json\/wp\/v2\/tags?post=13233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}